Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationDaniel Martín, Frederick L. Ferris, Maureen G. Maguire et al.|Ophthalmology|2012Cited by 1.7k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trialAlbert M. Maguire, Jean Bennett, Katherine A. High et al.|The Lancet|2009Cited by 857
Diabetic Retinopathy Preferred Practice Pattern®Christina J. Flaxel, Gui‐Shuang Ying, Ron A. Adelman et al.|Ophthalmology|2019Cited by 703
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular DegenerationMaureen G. Maguire, Stuart L. Fine, Daniel Martín et al.|Ophthalmology|2016Cited by 702
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments TrialsJuan E. Grunwald, Daniel Martín, Stephanie A. Hagstrom et al.|Ophthalmology|2013Cited by 585